<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04263844</url>
  </required_header>
  <id_info>
    <org_study_id>IndonesiaUAnes 051</org_study_id>
    <nct_id>NCT04263844</nct_id>
  </id_info>
  <brief_title>Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention</brief_title>
  <official_title>Comparison of Efficacy of Premedication Between Dexmedetomidine and Midazolam Intranasal for the Prevention of Emergence Delirium in Children Undergoing Ophthalmic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a double-blind clinical trial, in pediatric patients aged 1-12 years with
      physical status ASA (American Society of Anesthesiology) 1 and 2 who underwent eye surgery
      under general anesthesia using Sevoflurane inhalation agents, in investigator institution
      during February-May 2019.. There were 64 children obtained by consecutive sampling, who
      underwent eye surgery in investigator institution during February-May 2019. The subjects then
      grouped into dexmedetomidine group and midazolam group. Effectiveness was assessed from
      Emergence Delirium (ED) events, recovery time, and post-premedication desaturation events.
      Data analysis using Chi Square test and Mann-Whitney test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There were 64 children obtained by consecutive sampling, The subjects then grouped into
      dexmedetomidine group and midazolam group. Effectiveness was assessed from ED events,
      recovery time, and post-premedication desaturation events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 10, 2019</start_date>
  <completion_date type="Actual">October 10, 2019</completion_date>
  <primary_completion_date type="Actual">October 10, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of emergence delirium thirty minutes after surgery</measure>
    <time_frame>30 minutes</time_frame>
    <description>PAED score was measured</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Emergence Delirium</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subject will receive premedication with intranasal dexmedetomidine 1 mcg/kgBB thirty minutes before induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subject will receive premedication with intranasal midazolam 0,1 mg/kgBB thirty minutes before induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intranasal dexmedetomidine</intervention_name>
    <description>subject will receive premedication with intranasal dexmedetomidine thirty minutes before induction</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intranasal Midazolam</intervention_name>
    <description>subject will receive premedication with intranasal midazolam thirty minutes before induction</description>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children undergoing ophthalmologic surgery with general anesthesia

          -  children aged 1 - 12 years old

          -  physical status ASA 1-2

          -  signing informed consent

        Exclusion Criteria:

          -  children undergoing emergency surgery

          -  children with PICU nursing after surgery

          -  children with psychological and neurological condition

          -  children with allergic history to dexmedetomidine and midazolam

          -  children with history of malignant hyperthermia or family history of malignant
             hyperthermia

          -  children with possibility of difficult intubation and ventilation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andi Ade W Ramlan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indonesia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cipto Mangunkusumo Cental National Hospital</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <results_reference>
    <citation>Cohen MM, Cameron CB, Duncan PG. Pediatric anesthesia morbidity and mortality in the perioperative period. Anesth Analg. 1990 Feb;70(2):160-7.</citation>
    <PMID>2301747</PMID>
  </results_reference>
  <results_reference>
    <citation>Mohkamkar M Bs, Farhoudi F Md, Alam-Sahebpour A Md, Mousavi SA Md, Khani S PhD, Shahmohammadi S BSc. Postanesthetic Emergence Agitation in Pediatric Patients under General Anesthesia. Iran J Pediatr. 2014 Apr;24(2):184-90.</citation>
    <PMID>25535538</PMID>
  </results_reference>
  <results_reference>
    <citation>Kim JH. Mechanism of emergence agitation induced by sevoflurane anesthesia. Korean J Anesthesiol. 2011 Feb;60(2):73-4. doi: 10.4097/kjae.2011.60.2.73. Epub 2011 Feb 25.</citation>
    <PMID>21390159</PMID>
  </results_reference>
  <results_reference>
    <citation>Silva LM, Braz LG, MÃ³dolo NS. Emergence agitation in pediatric anesthesia: current features. J Pediatr (Rio J). 2008 Mar-Apr;84(2):107-13. doi: 10.2223/JPED.1763. Review.</citation>
    <PMID>18372935</PMID>
  </results_reference>
  <results_reference>
    <citation>Key KL, Rich C, DeCristofaro C, Collins S. Use of propofol and emergence agitation in children: a literature review. AANA J. 2010 Dec;78(6):468-73. Review.</citation>
    <PMID>21309294</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee CJ, Lee SE, Oh MK, Shin CM, Kim YJ, Choe YK, Cheong SH, Lee KM, Lee JH, Lim SH, Kim YH, Cho KR. The effect of propofol on emergence agitation in children receiving sevoflurane for adenotonsillectomy. Korean J Anesthesiol. 2010 Aug;59(2):75-81. doi: 10.4097/kjae.2010.59.2.75. Epub 2010 Aug 20.</citation>
    <PMID>20740210</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 7, 2020</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2020</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Andi Ade Wijaya Ramlan</investigator_full_name>
    <investigator_title>Principal Investigator, Pediatric Anesthesia Division</investigator_title>
  </responsible_party>
  <keyword>emergence, delirium, dexmedetomidine, midazolam, pediatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

